Medical Dialogues
  • Dermatology
Login Register
This site is intended for healthcare professionals only
Login Register
  • MD Brand Connect
  • Vaccine Hub
  • MDTV
    • Breaking News
    • Medical News Today
    • Health News Today
    • Latest
    • Journal Club
    • Medico Legal Update
    • Latest Webinars
    • MD Shorts
    • Health Dialogues
  • Fact Check
  • Health Dialogues
Medical Dialogues
  • Medical News & Guidelines
      • Anesthesiology
      • Cardiology and CTVS
      • Critical Care
      • Dentistry
      • Dermatology
      • Diabetes and Endocrinology
      • ENT
      • Gastroenterology
      • Medicine
      • Nephrology
      • Neurology
      • Obstretics-Gynaecology
      • Oncology
      • Ophthalmology
      • Orthopaedics
      • Pediatrics-Neonatology
      • Psychiatry
      • Pulmonology
      • Radiology
      • Surgery
      • Urology
      • Laboratory Medicine
      • Diet
      • Nursing
      • Paramedical
      • Physiotherapy
  • Health news
      • Doctor News
      • Government Policies
      • Hospital & Diagnostics
      • International Health News
      • Medical Organization News
      • Medico Legal News
      • NBE News
      • NMC News
  • Fact Check
      • Bone Health Fact Check
      • Brain Health Fact Check
      • Cancer Related Fact Check
      • Child Care Fact Check
      • Dental and oral health fact check
      • Diabetes and metabolic health fact check
      • Diet and Nutrition Fact Check
      • Eye and ENT Care Fact Check
      • Fitness fact check
      • Gut health fact check
      • Heart health fact check
      • Kidney health fact check
      • Medical education fact check
      • Men's health fact check
      • Respiratory fact check
      • Skin and hair care fact check
      • Vaccine and Immunization fact check
      • Women's health fact check
  • AYUSH
    • Ayurveda
    • Homeopathy
    • Siddha
    • Unani
    • Yoga
  • State News
      • Andaman and Nicobar Islands
      • Andhra Pradesh
      • Arunachal Pradesh
      • Assam
      • Bihar
      • Chandigarh
      • Chattisgarh
      • Dadra and Nagar Haveli
      • Daman and Diu
      • Delhi
      • Goa
      • Gujarat
      • Haryana
      • Himachal Pradesh
      • Jammu & Kashmir
      • Jharkhand
      • Karnataka
      • Kerala
      • Ladakh
      • Lakshadweep
      • Madhya Pradesh
      • Maharashtra
      • Manipur
      • Meghalaya
      • Mizoram
      • Nagaland
      • Odisha
      • Puducherry
      • Punjab
      • Rajasthan
      • Sikkim
      • Tamil Nadu
      • Telangana
      • Tripura
      • Uttar Pradesh
      • Uttrakhand
      • West Bengal
  • Medical Education
      • Ayush Education News
      • Dentistry Education News
      • Medical Admission News
      • Medical Colleges News
      • Medical Courses News
      • Medical Universities News
      • Nursing education News
      • Paramedical Education News
      • Study Abroad
  • Industry
      • Health Investment News
      • Health Startup News
      • Medical Devices News
      • Pharma News
      • Pharmacy Education News
      • Industry Perspective
  • MDTV
      • Health Dialogues MDTV
      • Health News today MDTV
      • Latest Videos MDTV
      • Latest Webinars MDTV
      • MD shorts MDTV
      • Medical News Today MDTV
      • Medico Legal Update MDTV
      • Top Videos MDTV
      • Health Perspectives MDTV
      • Journal Club MDTV
      • Medical Dialogues Show
This site is intended for healthcare professionals only
LoginRegister
Medical Dialogues
LoginRegister
  • Home
  • Medical news & Guidelines
    • Anesthesiology
    • Cardiology and CTVS
    • Critical Care
    • Dentistry
    • Dermatology
    • Diabetes and Endocrinology
    • ENT
    • Gastroenterology
    • Medicine
    • Nephrology
    • Neurology
    • Obstretics-Gynaecology
    • Oncology
    • Ophthalmology
    • Orthopaedics
    • Pediatrics-Neonatology
    • Psychiatry
    • Pulmonology
    • Radiology
    • Surgery
    • Urology
    • Laboratory Medicine
    • Diet
    • Nursing
    • Paramedical
    • Physiotherapy
  • Health news
    • Doctor News
    • Government Policies
    • Hospital & Diagnostics
    • International Health News
    • Medical Organization News
    • Medico Legal News
    • NBE News
    • NMC News
  • Fact Check
    • Bone Health Fact Check
    • Brain Health Fact Check
    • Cancer Related Fact Check
    • Child Care Fact Check
    • Dental and oral health fact check
    • Diabetes and metabolic health fact check
    • Diet and Nutrition Fact Check
    • Eye and ENT Care Fact Check
    • Fitness fact check
    • Gut health fact check
    • Heart health fact check
    • Kidney health fact check
    • Medical education fact check
    • Men's health fact check
    • Respiratory fact check
    • Skin and hair care fact check
    • Vaccine and Immunization fact check
    • Women's health fact check
  • AYUSH
    • Ayurveda
      • Ayurveda Giuidelines
      • Ayurveda News
    • Homeopathy
      • Homeopathy Guidelines
      • Homeopathy News
    • Siddha
      • Siddha Guidelines
      • Siddha News
    • Unani
      • Unani Guidelines
      • Unani News
    • Yoga
      • Yoga Guidelines
      • Yoga News
  • State News
    • Andaman and Nicobar Islands
    • Andhra Pradesh
    • Arunachal Pradesh
    • Assam
    • Bihar
    • Chandigarh
    • Chattisgarh
    • Dadra and Nagar Haveli
    • Daman and Diu
    • Delhi
    • Goa
    • Gujarat
    • Haryana
    • Himachal Pradesh
    • Jammu & Kashmir
    • Jharkhand
    • Karnataka
    • Kerala
    • Ladakh
    • Lakshadweep
    • Madhya Pradesh
    • Maharashtra
    • Manipur
    • Meghalaya
    • Mizoram
    • Nagaland
    • Odisha
    • Puducherry
    • Punjab
    • Rajasthan
    • Sikkim
    • Tamil Nadu
    • Telangana
    • Tripura
    • Uttar Pradesh
    • Uttrakhand
    • West Bengal
  • Medical Education
    • Ayush Education News
    • Dentistry Education News
    • Medical Admission News
    • Medical Colleges News
    • Medical Courses News
    • Medical Universities News
    • Nursing education News
    • Paramedical Education News
    • Study Abroad
  • Industry
    • Health Investment News
    • Health Startup News
    • Medical Devices News
    • Pharma News
      • CDSCO (Central Drugs Standard Control Organisation) News
    • Pharmacy Education News
    • Industry Perspective
  • Home
  • Cardiology-CTVS
  • Cardiology & CTVS Perspective
  • Aspirin in Primary...

Aspirin in Primary Prevention of Stroke-Review of Evidence Through the Needs of Indian Clinical Settings

Dr. Rahul R. PatilWritten by Dr. Rahul R. Patil Published On 2025-07-07T11:42:49+05:30  |  Updated On 7 July 2025 1:59 PM IST
Aspirin in Primary Prevention of Stroke-Review of Evidence Through the Needs of Indian Clinical Settings
  • facebook
  • twitter
  • linkedin
  • whatsapp
  • Telegram
  • Email

Introduction: Stroke Burden and Aspirin's Role

The stroke burden in India is substantial and growing, with an incidence of 119-145 per 100,000 annually (~0.12–0.15%). Importantly, 20–30% of strokes occur in individuals under 50, (1) substantially younger than the 70–75 years typically reported in Western populations. (2) Ischemic stroke is the most common subtype across all Population-Based Stroke Registries (PBSRs) in India, accounting for approximately 60% to 85% of all stroke cases. (3)

Stroke remains a leading cause of death and DALYs in India, highlighting the urgent need for effective primary prevention strategies. (1) Aspirin, with its well-established antiplatelet efficacy, continues to be widely considered for reducing the risk of first atherothrombotic (ischemic) stroke in at-risk individuals. (4)

Aspirin in Atherothrombotic Stroke: Evidence Review

Multiple large-scale studies have evaluated the role of aspirin in the primary prevention of stroke among at-risk populations. The ASCEND trial (A Study of Cardiovascular Events in Diabetes), a randomized, placebo-controlled trial involving 15,480 patients with diabetes but no prior CVD. Over a mean follow-up of 7.4 years, aspirin use was associated with a significant 12% relative reduction in serious vascular events, including ischemic stroke [HR: 0.88; 95% CI: 0.79–0.97; p = 0.01]. (5)

A recent meta-analysis of 11 randomized controlled trials, including both men and women without prior cardiovascular events, found a significant reduction in overall stroke risk in women using aspirin (OR 0.85; 95% CI: 0.73–0.99; p = 0.03), driven primarily by a 24% reduction in ischemic stroke [OR 0.76; 95% CI: 0.63–0.93; p = 0.008]. (6)

A comprehensive meta-analysis by the Antithrombotic Trialists’ Collaboration, including over 135,000 high-risk patients, demonstrated that aspirin reduced the risk of non-fatal stroke by approximately 25% compared to control. Among patients with prior stroke or transient ischemic attack, aspirin use resulted in an absolute risk reduction of 36 per 1000 over two years. Low-dose aspirin (75–150 mg daily) was found to be as effective as higher doses for long-term stroke prevention. (7)

Aspirin in Primary ASCVD Prevention - Where Guidelines Stand?

Guideline

Target Population

Recommendation for CVD (Including Stroke) Prevention

Conditions

DCRM 2.0 [2024] (8)

Adults aged 40–59 with ≥2 CV risk factors (e.g., high Lp(a), HT, T2DM, dyslipidemia)

Low-dose aspirin may be considered

India-aligned criteria; individualized decision based on bleeding risk

USPSTF [2022] (9)

Adults aged 40–59 years with ≥10% 10-year ASCVD risk

Recommends initiating aspirin

If bleeding risk is not elevated

ESC [2021] (10)

Individuals with hypertension, dyslipidemia, and F/H of early ASCVD

Low-dose aspirin may be considered

If overall CV risk is high (SCORE2 ≥5%) and bleeding risk is low

ACC/AHA [2019] (10)

Adults aged 40–70 years at high ASCVD risk

Supports considering aspirin

Provided bleeding risk is low

India-Specific Considerations: Stroke Risk Profile Is Different

The early onset of stroke in India is primarily driven by poorly controlled cardiometabolic factors—hypertension, diabetes, dyslipidemia—and compounded by genetic risks such as elevated lipoprotein(a) and the South Asian “thin-fat” phenotype, marked by high visceral adiposity despite normal BMI, thereby supporting the need for considering selective aspirin initiation in appropriately risk-stratified individuals. (3)

Nearly 76% of Indian T2DM cases are uncontrolled; (11) only 1 in 3 patients with hypertension are even diagnosed. (12) In such a landscape, primary prevention tools like aspirin deserve contextual application, particularly in patients with overlapping CV risks.

Clinical Application: A Case-Based Insight into Stroke Prevention


Decision-support tools like AspirinGuide can aid clinicians in balancing benefits and bleeding risks in such high-risk individuals.

Key Takeaways

  • Aspirin remains a clinically relevant option for the primary prevention of ischemic stroke in appropriately selected high-risk individuals, in Indian clinical settings.
  • With India’s younger stroke onset, high burden of uncontrolled T2DM, hypertension, and genetic predispositions like elevated Lp(a), personalized risk-benefit assessment is critical.
  • Guideline-aligned, context-specific use, supported by tools like AspirinGuide, can help clinicians optimize prevention while minimizing bleeding risks.

Reference:

1. Behera, D.K., Rahut, D.B. & Mishra, S. Analyzing stroke burden and risk factors in India using data from the Global Burden of Disease Study. Sci Rep 14, 22640 (2024). https://doi.org/10.1038/s41598-024-72551-4

2. Donkor ES. Stroke in the 21st Century: A Snapshot of the Burden, Epidemiology, and Quality of Life. Stroke Res Treat. 2018;2018:3238165. Published 2018 Nov 27. doi:10.1155/2018/3238165

3. Rangamani, Sukanya et al. “Stroke incidence, mortality, subtypes in rural and urban populations in five geographic areas of India (2018-2019): results from the National Stroke Registry Programme.” The Lancet regional health. Southeast Asia vol. 23 100308. 28 Oct. 2023, doi:10.1016/j.lansea.2023.100308

4. Hussain, Masaraf, et al. "Antiplatelet Effect of Aspirin in Ischemic Stroke: A Hospital-based Study." Journal of Advances in Medicine and Medical Research, vol. 33, no. 22, 2021, pp. 237–244. Article no. JAMMR.76481.

5. ASCEND Study Collaborative Group et al. “Effects of Aspirin for Primary Prevention in Persons with Diabetes Mellitus.” The New England journal of medicine vol. 379,16 (2018): 1529-1539. doi:10.1056/NEJMoa1804988

6. Gdovinova, Zuzana et al. “Aspirin for Primary Stroke Prevention; Evidence for a Differential Effect in Men and Women.” Frontiers in neurology vol. 13 856239. 21 Jun. 2022, doi:10.3389/fneur.2022.856239

7. Antithrombotic Trialists' Collaboration. “Collaborative meta-analysis of randomised trials of antiplatelet therapy for prevention of death, myocardial infarction, and stroke in high risk patients.” BMJ (Clinical research ed.) vol. 324,7329 (2002): 71-86. doi:10.1136/bmj.324.7329.71

8. Handelsman, Yehuda et al. “DCRM 2.0: Multispecialty practice recommendations for the management of diabetes, cardiorenal, and metabolic diseases.” Metabolism: clinical and experimental vol. 159 (2024): 155931. doi:10.1016/j.metabol.2024.155931

9. Della Bona, Roberta, et al. "Aspirin in Primary Prevention: Looking for Those Who Enjoy It." Journal of Clinical Medicine, vol. 13, no. 14, 2024, article 4148, https://doi.org/10.3390/jcm13144148. Accessed 31 May 2025.

10. Visseren, Frank L J et al. “2021 ESC Guidelines on cardiovascular disease prevention in clinical practice.” European heart journal vol. 42,34 (2021): 3227-3337. doi:10.1093/eurheartj/ehab484

11. Ismail IM, Naik PR. Prevalence and Determinants of Uncontrolled Diabetes Mellitus: A Community-Based Study from Karnataka, India. Natl J Community Med. 2024;15(10):842–849. doi:10.55489/njcm.151020244459

12. Varghese, Jithin Sam et al. “Hypertension Diagnosis, Treatment, and Control in India.” JAMA network open vol. 6,10 e2339098. 2 Oct. 2023, doi:10.1001/jamanetworkopen.2023.39098

Abbreviations: DALYs – Disability-Adjusted Life Years, PBSR – Population-Based Stroke Registry, ASCEND – A Study of Cardiovascular Events in Diabetes, CVD – Cardiovascular Disease, HR – Hazard Ratio, CI – Confidence Interval, OR – Odds Ratio, DCRM – Diabetes, Cardiorenal, and Metabolic Diseases, Lp(a) – Lipoprotein(a), HT – Hypertension, T2DM – Type 2 Diabetes Mellitus, CV – Cardiovascular, USPSTF – United States Preventive Services Task Force, ASCVD – Atherosclerotic Cardiovascular Disease, ESC – European Society of Cardiology, F/H – Family History, ACC/AHA – American College of Cardiology / American Heart Association, SCORE2 – Systematic Coronary Risk Estimation 2, BMI – Body Mass Index, E/O – Either/Or

ascvdcvdstrokestroke riskstroke risk in menaspirinaspirin in strokeaspirin for strokestroke preventive therapyaspirin safetyattantithrombotic trialistaspirin efficacycvd preventionascvd preventionstroke preventionecosprinecosprin avecosprin in strokeecosprin safetydr rahul r patil
Dr. Rahul R. Patil
Dr. Rahul R. Patil

    Dr. Rahul R. Patil, MD (Med), DNB (Card), is Hon. Asst. Professor of Cardiology at Sassoon General Hospital & B. J. Medical College, Pune, and a Senior Consultant Cardiologist at Ruby Hall Clinic, Pune. He holds FICN, FESC, FACC, FSCAI, and a Fellowship in Interventional Cardiology (Netherlands).

    Show Full Article
    Next Story

    Editorial

    Aspirin in Primary Prevention of Stroke-Review of Evidence Through the Needs of Indian Clinical Settings

    Aspirin in Primary Prevention of Stroke-Review of Evidence Through the Needs of Indian Clinical...

    Dapagliflozin Shines in Post-TAVI Patients:DAPA-TAVI Trial Findings

    Dapagliflozin Shines in Post-TAVI Patients:DAPA-TAVI Trial Findings

    Identifying Candidates for Aspirin in Primary Prevention: Men Aged 40-50 with Hypertension, Dyslipidemia, and Familial ASCVD Risk

    Identifying Candidates for Aspirin in Primary Prevention: Men Aged 40-50 with Hypertension,...

    Featured image representing thinking

    Is Pharma Marketing Going Through "Thinking Recession"?

    Beyond BMI: Why Pioglitazone Deserves a Place in Managing Thin-Fat Type 2 Diabetes in India

    Beyond BMI: Why Pioglitazone Deserves a Place in Managing 'Thin-Fat' Type 2 Diabetes in India

    View All

    Journal Club Today

    Decades After Diagnosis, Childhood Cancer Survivors Still Vulnerable to Severe COVID: Study Shows

    Decades After Diagnosis, Childhood Cancer Survivors Still Vulnerable to Severe COVID: Study Shows

    View All

    Health News Today

    Health Bulletin 5/July/ 2025

    Health Bulletin 5/July/ 2025

    View All
    © 2022 All Rights Reserved.
    Powered By: Hocalwire
    X
    We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok